Glucose-lowering therapies in patients with diabetes mellitus and chronic kidney disease
Expansion of diabetic population (predominantly due to type 2 diabetes mellitus) with chronic kidney disease (CKD) comorbidity constitutes one of the major challenges in modern medicine.Throughout the course of diabetes nephropathy development, from its debut to the terminal stage, survival...
Guardado en:
| Autores principales: | , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN RU |
| Publicado: |
Endocrinology Research Centre
2013
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/c7d93a2056e945a7a7956980ca44e73b |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:c7d93a2056e945a7a7956980ca44e73b |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:c7d93a2056e945a7a7956980ca44e73b2021-11-14T09:00:18ZGlucose-lowering therapies in patients with diabetes mellitus and chronic kidney disease2072-03512072-037810.14341/2072-0351-823https://doaj.org/article/c7d93a2056e945a7a7956980ca44e73b2013-09-01T00:00:00Zhttps://www.dia-endojournals.ru/jour/article/view/823https://doaj.org/toc/2072-0351https://doaj.org/toc/2072-0378Expansion of diabetic population (predominantly due to type 2 diabetes mellitus) with chronic kidney disease (CKD) comorbidity constitutes one of the major challenges in modern medicine.Throughout the course of diabetes nephropathy development, from its debut to the terminal stage, survival rate and quality of life are lower than those of other categories of patients. This indicates crucial role of hyperglycemia in accelerated metabolic degradation typical of CKD.Renal disease severely narrows the spectrum of available glucose-lowering agents. Concurrent treatment for hypertension and dyslipidemia, as well as anti-platelet therapy and stimulation of erythropoiesis becomes a complex issue. A creative and patient-oriented approach with clear metabolic and cardiovascular goals should be instrumental in its solution.Minara Shamkhalovna ShamkhalovaIvona Renata Yarek-MartynovaNatalya Petrovna TrubitcynaMarina Vladimirovna ShestakovaEndocrinology Research Centrearticlediabetes mellituschronic kidney diseaseglycemic controlNutritional diseases. Deficiency diseasesRC620-627ENRUСахарный диабет, Vol 16, Iss 3, Pp 97-102 (2013) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN RU |
| topic |
diabetes mellitus chronic kidney disease glycemic control Nutritional diseases. Deficiency diseases RC620-627 |
| spellingShingle |
diabetes mellitus chronic kidney disease glycemic control Nutritional diseases. Deficiency diseases RC620-627 Minara Shamkhalovna Shamkhalova Ivona Renata Yarek-Martynova Natalya Petrovna Trubitcyna Marina Vladimirovna Shestakova Glucose-lowering therapies in patients with diabetes mellitus and chronic kidney disease |
| description |
Expansion of diabetic population (predominantly due to type 2 diabetes mellitus) with chronic kidney disease (CKD) comorbidity constitutes one of the major challenges in modern medicine.Throughout the course of diabetes nephropathy development, from its debut to the terminal stage, survival rate and quality of life are lower than those of other categories of patients. This indicates crucial role of hyperglycemia in accelerated metabolic degradation typical of CKD.Renal disease severely narrows the spectrum of available glucose-lowering agents. Concurrent treatment for hypertension and dyslipidemia, as well as anti-platelet therapy and stimulation of erythropoiesis becomes a complex issue. A creative and patient-oriented approach with clear metabolic and cardiovascular goals should be instrumental in its solution. |
| format |
article |
| author |
Minara Shamkhalovna Shamkhalova Ivona Renata Yarek-Martynova Natalya Petrovna Trubitcyna Marina Vladimirovna Shestakova |
| author_facet |
Minara Shamkhalovna Shamkhalova Ivona Renata Yarek-Martynova Natalya Petrovna Trubitcyna Marina Vladimirovna Shestakova |
| author_sort |
Minara Shamkhalovna Shamkhalova |
| title |
Glucose-lowering therapies in patients with diabetes mellitus and chronic kidney disease |
| title_short |
Glucose-lowering therapies in patients with diabetes mellitus and chronic kidney disease |
| title_full |
Glucose-lowering therapies in patients with diabetes mellitus and chronic kidney disease |
| title_fullStr |
Glucose-lowering therapies in patients with diabetes mellitus and chronic kidney disease |
| title_full_unstemmed |
Glucose-lowering therapies in patients with diabetes mellitus and chronic kidney disease |
| title_sort |
glucose-lowering therapies in patients with diabetes mellitus and chronic kidney disease |
| publisher |
Endocrinology Research Centre |
| publishDate |
2013 |
| url |
https://doaj.org/article/c7d93a2056e945a7a7956980ca44e73b |
| work_keys_str_mv |
AT minarashamkhalovnashamkhalova glucoseloweringtherapiesinpatientswithdiabetesmellitusandchronickidneydisease AT ivonarenatayarekmartynova glucoseloweringtherapiesinpatientswithdiabetesmellitusandchronickidneydisease AT natalyapetrovnatrubitcyna glucoseloweringtherapiesinpatientswithdiabetesmellitusandchronickidneydisease AT marinavladimirovnashestakova glucoseloweringtherapiesinpatientswithdiabetesmellitusandchronickidneydisease |
| _version_ |
1718429612478824448 |